基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
The new Coronavirus disease or COVID-19 is a contagious viral/immune-logical systemic disorder with predominantly respiratory features caused by human infection with SARS-CoV-2, which is rapidly spreading from person-to-person all around the world as a pandemic. The new outbreak of COVID-19 first appeared in Wuhan, China in December 2019. This virus is transmitted from human to human in various ways including air, aerosol, touching, and fecal-oral ways. The SARS-CoV-2 survives for several days in the environment. The SARS-CoV-2 virus multiplies within the cells of mouth-throat or nose-throat, and despite the production of antibodies by the human immune system, if the virus continues to multiply and progress, it will enter the bloodstream and reach its target organ, the lungs. It takes an incubation period of one to fourteen days for the initial symptoms/signs of disease to appear as fever, dry cough, and fatigue. Finally, shortness of breath due to pneumonia/pneumonitis with or without Acute Respiratory Distress Syndrome (ARDS) causes the patient to be hospitalized and transferred to ICU. Older people with underlying disorders account for the majority of deaths from COVID-19, while children under the age of 15 - 20 are the main carriers of the SARS-CoV-2. About 40% of patients with COVID-19 are asymptomatic and, 40% mild, 15%;severe, and 5% are critical COVID-19. COVID-19 Molecular Diagnostic Tests and COVID-19 Antibody Tests are two types of diagnostic kit tests for identification of the SARS-CoV-2 and the High Resolution Computerised Tomography (HRCT) scanning of lungs is the best imaging method for detecting pneumonia/pneumonitis and assessing its severity. This paper is intended to present a health system called COVID-19 Referral System for screening and developing very sensitive diagnostic criteria as Persian Gulf Criteria for diagnosis of COVID-19. By using these two methods and performing the SARS-CoV-2 kit tests more and more widely, and performing accurate isolation of patients and virus carriers and com
推荐文章
SARS-CoV-2变异株的遗传学特征和致病特点
SARS病毒
遗传变异
突变
毒力
新型冠状病毒
奥密克戎
新型冠状病毒肺炎患者恢复期肛拭子中SARS-CoV-2核酸检测结果评价
肺炎,病毒性
冠状病毒属
恢复期
新型冠状病毒肺炎
新型冠状病毒
肛拭子
核酸检测
SARS-CoV-2辅助蛋白ORF8的功能及研究进展
SARS病毒
免疫逃避
突变
进化,分子
新型冠状病毒
ORF8
COVID-19免疫相关发病机制与免疫治疗研究进展
新型冠状病毒肺炎
新型冠状病毒
免疫
药物
治疗
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Practical Guideline for Screening the Patients with SARS-CoV-2 Infection and Persian Gulf Criteria for Diagnosis of COVID-19
来源期刊 传染病进展(英文) 学科 医学
关键词 COVID-19 SARS-CoV-2 Human Novel Co V SARS-CoV-1 MERS-CoV COVID-19 Referral System Persian Gulf Criteria
年,卷(期) 2020,(S1) 所属期刊栏目
研究方向 页码范围 67-93
页数 27页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
COVID-19
SARS-CoV-2
Human
Novel
Co
V
SARS-CoV-1
MERS-CoV
COVID-19
Referral
System
Persian
Gulf
Criteria
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
传染病进展(英文)
季刊
2164-2648
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
150
总下载数(次)
0
总被引数(次)
0
论文1v1指导